Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma (Q34225286)

31 July 2017

Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma (English)

1 reference

31 July 2017

hepatocellular carcinoma

1 reference

Chao-Ping Ye

1

1 reference

31 July 2017

Cheng-Zhi Qiu

2

1 reference

31 July 2017

Zhong-Xin Huang

3

1 reference

31 July 2017

Qi-Chen Su

4

1 reference

31 July 2017

Wei Zhuang

5

1 reference

31 July 2017

Rui-Lan Wu

6

1 reference

31 July 2017

Xin-Feng Li

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

World Journal of Gastroenterology

31 July 2017

1 reference

31 July 2017

13

1 reference

31 July 2017

46

1 reference

31 July 2017

6264-6268

1 reference

Survivin modulates microtubule dynamics and nucleation throughout the cell cycle

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Hepatocellular carcinoma: the need for progress.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

A survivin gene signature predicts aggressive tumor behavior

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Regulation of microtubule stability and mitotic progression by survivin.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Survivin promotes cell proliferation in human hepatocellular carcinoma.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171241

Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.

28 October 2018

1 reference

12 December 2020

Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

1 reference

12 December 2020

Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma

1 reference

12 December 2020

Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways

1 reference

12 December 2020

Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy

1 reference

12 December 2020

Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma

1 reference

12 December 2020

Effect of survivin on cell proliferation and apoptosis in gastric cancer

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.13.6264

1 reference

31 July 2017

1 reference

31 July 2017

1 reference